Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 14/20 | 0.53 |
| ▸ | ROS1 | P08922 | 6/20 | 0.51 |
| ▸ | EGFR | P00533 | 3/20 | 0.45 |
| ▸ | CCNK | O75909 | 1/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.41 |
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | CCND3 | P30281 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.41 |
| ▸ | INSR | P06213 | 1/20 | 0.41 |
| ▸ | TTK | P33981 | 1/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26906900 | 0.86 | EGFR (0.59) | ALKROS1EGFR | |
| SCHEMBL26906871 | 0.85 | EGFR (0.50) | ALKROS1EGFRINSR | |
| Hydrochloric Acid SCHEMBL29257809 | 0.78 | EGFR (0.56) | ALKEGFRLRRK2 | |
| SCHEMBL30659734 | 0.77 | ALK (0.62) | ALKROS1EGFRINSR | |
| SCHEMBL30701583 | 0.76 | BRD4 (0.44) | ALKEGFR | |
| SCHEMBL26906881 | 0.76 | ALK (0.54) | ALKROS1EGFRINSRLRRK2 | |
| SCHEMBL26906870 | 0.76 | EGFR (0.60) | ALKROS1EGFRINSR | |
| SCHEMBL25144687 | 0.75 | EGFR (0.48) | ALKROS1EGFRINSR | |
| Hydrochloric Acid SCHEMBL29257842 | 0.75 | EGFR (0.45) | ALKEGFRCCNKCCNA2CDK2 | |
| SCHEMBL22595127 | 0.74 | NUAK1 (0.44) | ALKEGFRCCNKCCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117120424-A | Pyrimidine derivatives having protein kinase inhibitory activity and therapeutic combinations comprising the same | 泰拉佩克斯有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117120424-A | Pyrimidine derivatives having protein kinase inhibitory activity and therapeutic combinations comprising the same | 泰拉佩克斯有限公司 | 2023-11-24 | — | — | CN | disclosed |